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 Abstract 
 Background: The requirements for a comprehensive stroke center (CSC) include the capabil-
ity to perform endovascular stroke therapy (EST). EST is a complex process requiring early 
identification of appropriate patients and effective delivery of intervention. In order to pro-
vide prompt intervention for stroke, CSCs have been established away from large academic 
centers in community-based hospitals. We hypothesized that quantifiable improvements 
would occur during the first 2 years of a community-based CSC as the processes and person-
nel evolved. We report the results over time of EST at a new community-based CSC.  Methods: 
We have retrospectively analyzed demographic data and outcome metrics of EST from the 
initiation phase of a new community-based CSC. Data was divided into year 1 and year 2. Sta-
tistical analysis (Student’s t test and Fisher’s exact test) was performed to compare the patient 
population and outcomes across the two time periods. Outcome variables included the 
thrombolysis in cerebral infarction (TICI) score, a change in the NIH stroke scale score and the 
modified Rankin Scale (mRS) score. Analysis of variance (ANOVA) was used to statistically 
analyze the relationship between population variables and outcome. Computed tomography 
(CT) angiography and CT perfusion analysis were used to select patients for EST. Approxi-
mately half of the patients undergoing EST were excluded from receiving intravenous recom-
binant tissue plasminogen activator (IV rt-PA) by standard criteria, while the other half showed 
no sign of improvement following 1 h of IV rt-PA treatment. Mechanical thrombolysis with a 
stentriever was performed in the majority of cases with or without intra-arterial medication. 
The majority of treated occlusions were in the middle cerebral artery.  Results: A total of 18 
patients underwent EST during year 1 and year 2. A statistically significant increase in good 
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outcomes (mRS score  ≤ 2 at discharge) was seen from year 1 to year 2 (p = 0.05). There were 
trends towards faster interventions, decreased complications and mortality as well as an im-
proved TICI score from year 1 to year 2. With ANOVA, mortality was statistically correlated 
with age (p = 0.06), while decreases in the NIH stroke scale (NIHSS) score following EST cor-
related with decreased mortality (p = 0.01). A higher TICI score was significantly associated 
with a decreased NIHSS score following EST (p = 0.01).  Conclusions: At a new community-
based CSC, improved outcome occurred from year 1 to year 2, and trends towards decreased 
mortality, fewer complications, and improved revascularization were observed. Furthermore, 
the data shows that improvement in NIHSS score after EST is associated with decreased mor-
tality following stroke in this setting, implying a net benefit.  © 2015 S. Karger AG, Basel 
 Introduction 
 The Brain Attack Coalition (BAC) defined the requirements for the establishment of 
primary stroke centers in 2000 and comprehensive stroke centers (CSCs) in 2005  [1, 2] . 
Subsequently, many hospital systems within the United States have established CSCs. In late 
2011, the Kennedy Health System (Camden and Gloucester Counties, N.J., USA) initiated a CSC 
at one of its three campuses. This CSC is a referral center for all three hospitals within its 
health system as well as for the local community. This CSC is also a joint venture with a 
regional academic medical center (Thomas Jefferson University, Philadelphia, Pa., USA). 
Neurologists employed by the hospital and telemedicine stroke neurologists based at the 
academic center provide vascular neurology coverage. Endovascular stroke therapy (EST) is 
carried out by two interventional neurosurgeons with joint appointments at both the hospital 
system and the academic center. The purpose of this article is to review the outcomes of 
patients who received EST at a new CSC and look at trends in outcomes over time. In the liter-
ature, we could not identify any normative data on the initiation phase of a CSC in the United 
States. Our contribution is to help define expected progress during such a start-up phase and 
the utilization of EST during that period.
 Our hypothesis was that over time, outcomes improve as the system for providing EST 
evolves in terms of personnel, equipment, and protocols. Our data showed that there was a 
statistically significant increase in good outcomes from year 1 to year 2. There were also trends 
towards decreased mortality, decreased complications, and increased revascularization over 
time. Furthermore, improved revascularization and decreased NIH stroke scale (NIHSS) scores 
were significantly associated with decreased mortality and improved outcomes.
 Methods 
 A retrospective chart review was conducted on patients admitted to the CSC with the diag-
nosis of acute ischemic stroke and treated with EST from January 2012 (start of the CSC) 
through December 2013. Demographic data was collected along with outcome and treatment 
data including method of revascularization, thrombolysis in cerebral infarction (TICI) score 
 [3, 4] , and NIHSS score as established by the National Institute of Neurological Disorders and 
Stroke (NINDS). Data is divided into year 1 (January to December 2012) and year 2 (January 
to December 2013). For parametric data, significance testing was performed with a two-tailed 
Student t test, assuming equal variances using Excel 2011 (Microsoft, Inc., Redmond, Wash., 
USA). For nonparametric data, Fisher’s exact test for 2 × 2 contingency tables and one-way 
analysis of variance (ANOVA) testing was performed with SPSS (IBM, Inc., Armonk, N.Y., USA).
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 Demographic Data 
 For each patient, several stroke risk factors were recorded including age, history of prior 
stroke, hypertension, hyperlipidemia, atrial fibrillation, and smoking. Hypertension was 
defined as a previous history of hypertension as reported by the patient or family or an 
admission systolic blood pressure >180 mm Hg. Hyperlipidemia was recorded if the patient 
reported a history of hyperlipidemia or had total cholesterol >200 mg/dl on initial laboratory 
screening. Atrial fibrillation was recorded if the patient or family reported a history of atrial 
fibrillation or electrocardiography documented atrial fibrillation on admission.
 Selection for EST 
 The selection process for EST is described below; the process was not altered during the 
entire study period. Acute stroke patients were initially evaluated in the emergency department 
(ED) of one of the three hospitals in the system by an ED physician. A noncontrast head computed 
tomography (CT) scan was obtained, and a neurology consultation was requested. If the in-house 
neurologist was unavailable, a university-based neurologist conducted a telemedicine stroke 
consult. Standard criteria for administering intravenous recombinant tissue plasminogen acti-
vator (IV rt-PA) (Activase; Genentech, South San Francisco, Calif., USA) were used  [5] . If the 
patient was ineligible for IV rt-PA administration based on standard criteria or failed to improve 
after 1 h of IV rt-PA administration, a CT perfusion scan of the brain and a CT angiogram of the 
brain and the neck were performed. In multiple studies, CT perfusion of the brain has been noted 
to be valuable in defining penumbra versus core infarct and avoiding posttreatment hemorrhage 
 [6] . If, in those studies, a major perfusion deficit without an accompanying area of decreased 
blood volume (ischemic penumbra) was identified, a review of the CT angiogram was under-
taken to identify a corresponding occluded vessel  [7] . If such a vessel was identified, the patient 
was deemed a candidate for EST unless the decreased blood volume on perfusion imaging 
exceeded one third of the corresponding middle cerebral artery (MCA) territory. For posterior 
circulation ischemia, the decision to proceed with EST was based on whether there was major 
vessel occlusion on CT angiography, major neurological deficit, and significant penumbra on CT 
perfusion. Door-to-needle (DTN) time was the time from ED arrival to delivery of IV rt-PA for the 
patients who were able to receive the medication. Door-to-intervention (DTI) time was the time 
from ED arrival to procedure start time in the interventional suite. Procedure length was the time 
from procedure start to recorded procedure end time (catheters and sheaths removed from patient).
 Interventional Methods and Outcomes 
 General endotracheal anesthesia was used for all interventions. Electroencephalography, 
somatosensory evoked potentials, and brainstem auditory evoked responses were recorded 
during the procedures. Arterial access was obtained through the common femoral artery. A 
large bore sheath (7 or 8 Fr) was placed. Diagnostic angiography was first performed to 
confirm an arterial occlusion. Next, a guide catheter was brought up close to the skull base or 
into the petrous carotid. Depending on the operator’s preference, either thromboaspiration 
or mechanical retrieval (stentriever) was used. Thromboaspiration was performed with the 
Penumbra system (Penumbra Inc., Alameda, Calif., USA) using the standard technique. 
Mechanical retrieval based on a stentriever was done with either the Solitaire FR (ev3 Neuro-
vascular, Irvine, Calif., USA) or the Trevo Pro (Stryker Neurovascular, Fremont, Calif., USA). 
In two cases, emergent carotid angioplasty and stenting were performed following EST; a 
Viatrac balloon, Rx Acculink carotid stent and Emboshield NAV6 embolic protection device 
were used (Abbott Laboratories, Abbott Park, Ill., USA). At the operator’s discretion, small 
doses (2–5 mg) of either rt-PA and/or abciximab (2–5 mg) (Reopro; Eli Lilly and Co., India-
napolis, Ind., USA) were administered intra-arterially through the catheter during some EST 
procedures. In no case was intra-arterial (IA) medication the sole treatment.
D
ow
nl
oa
de
d 
by
: 
71
.2
24
.1
19
.9
8 
- 5
/3
/2
01
5 
1:
58
:0
4 
PM
238Cerebrovasc Dis Extra 2014;4:235–242
 DOI: 10.1159/000370060 
E X T R A
 Benardete and Nair: Endovascular Stroke Therapy Results Improve over Time: The 
‘Learning Curve’ at a New Comprehensive Stoke Center 
www.karger.com/cee
© 2015 S. Karger AG, Basel
 NIHSS scores were calculated on admission and 24 h after treatment. The degree of 
revascularization was assessed using the TICI scale as originally described by Higashida et al. 
 [4] . Disability at the time of discharge was measured based on the modified Rankin Scale 
(mRS)  [8] .
 Results 
 Demographic Data 
 The entire Kennedy Memorial Hospital system receives approximately 145,000 emer-
gency room visits per year. Hospital records indicate that during the 2-year period, 1,644 
patients were admitted to the hospital system with a diagnosis of stroke or transient ischemic 
attack. Of these, 91 (5.5%) received IV rt-PA. Nineteen patients (1.1%) were identified for EST 
treatment during the analysis period; however, 1 patient was transferred to the academic 
center when the biplane fluoroscopy equipment malfunctioned at the beginning of the 
procedure and could not be immediately repaired. This patient was excluded from the analysis.
 The average age of the patient population was 74.6 years. During the first year, the 
average age was 78.3, and 66.1 years in the second year. This difference was statistically 
significant although selection criteria did not change from year 1 to year 2. In total, 7 male 
and 11 female patients were treated. The mean NIHSS score prior to intervention in year 1 
was 19, and in year 2, it was 14 (p = 0.16). Hypertension, hyperlipidemia, and atrial fibrillation 
were highly represented among the patient population, while smoking and history of prior 
stroke were not ( table 1 ).
 In both year 1 and year 2, approximately half of the patients received IV rt-PA prior to 
intervention ( table 1 ). In order to be candidates for EST, these patients continued to have a 
significant deficit after 1 h of IV rt-PA administration. CT perfusion and CT angiography were 
also required to demonstrate an ischemic penumbra and a vessel occlusion. Other reasons for 
referral for EST in both year 1 and year 2 included: age >80 years (2 patients), unknown time 
of onset of symptoms (‘wake-up strokes’) (5 patients), >4.5 h from symptom onset (1 patient), 
and recent gastrointestinal hemorrhage (1 patient). For both year 1 and year 2, the majority 
Year 1 Year 2 p
Mean age, years 78.4 66.1 0.03
Min.–max. 63 – 89 34 – 88
Mean NIHSS score 19 14 0.16
Min.–max. 8 – 25 6 – 21
Male/female 3/8 4/3 0.33
% prior stroke 0 (0/11) 14 (1/7) 0.39
% smoker 9 (1/11) 29 (2/7) 0.53
 % HL 64 (7/11) 85 (6/7) 0.60
% Afib 45 (5/11) 28 (2/7) 0.64
% HTN 82 (9/11) 71 (5/7) 1.00
% IV rt-PA 55 (6/11) 57 (4/7) 1.00
 Mean NIHSS score = Mean NIHSS score on admission; Min.–max. = 
minimum to maximum values; % Afib = percentage of patients with 
atrial fibrillation; % HL = percentage of patients with hyperlipidemia; 
% HTN = percentage of patients with hypertension; % IV rt-PA = 
percentage of patients who had received IV rt-PA prior to ET. p values 
are based on Fisher’s exact test (see Methods section).
 Table 1.  Demographic data for 
acute stroke patients treated 
with EST in year 1 and year 2 at 
a new CSC
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of patients had MCA occlusions (year 1, 90%; year 2, 100%). The proportion of left (‘dominant’) 
hemisphere occlusions was not significantly different between year 1 and year 2 (0.7 vs. 0.43, 
p = 0.35).
 Outcome Data 
 The proportion of patients receiving EST with a good outcome (defined as mRS at 
discharge  ≤ 2) was significantly higher in year 2 compared to year 1 (p = 0.05;  table 2 ). There 
were also trends towards other outcome improvements in year 2 compared to year 1, but 
these did not reach statistical significance ( table 2 ). For example, the 30-day mortality rate 
fell from 36 to 14% from year 1 to year 2 (p = 0.6), while the rate of complete revascular-
ization (TICI score = 3) improved from year 1 to year 2 (absolute increase 30%, p = 0.33). The 
mean improvement in the NIHSS score 24 h after the procedure was similar over the two 
periods (year 1, score 5; year 2, score 6) ( table 3 ).
Year 1 Year 2 p
% discharge mRS score ≤2 9 (1/11) 57 (4/7) 0.05
%TICI score 3 27 (3/11) 57 (4/7) 0.33
% 30-day mortality 36 (4/11) 14 (1/7) 0.60
% MCA 90 (10/11) 100 (7/7) 1.00
% complication 27 (3/11) 14 (1/7) 1.00
% stentriever 73 (8/11) 85 (6/7) 1.00
% TICI score ≥2b 64 (7/11) 71 (5/7) 1.00
% IA medications 36 (4/11) 43 (3/7) 1.00
The fraction in parentheses is the number of patients with characteristics 
over the total. % discharge mRS score ≤2 = percentage of patients at 
discharge who had an mRS score ≤2 (independent); % TICI score 3 = 
percentage of patients with complete revascularization on the TICI scale; % 
MCA = percentage of patients with an MCA occlusion on angiography; % 
complication = percentage of patients who had a procedural complication; 
% stentreiver = percentage of patients treated with a stentriever as the 
primary endovascular device; % TICI ≥2b score = percentage of patients 
with a revascularization score on the TICI scale of 2b or higher; % IA 
medications = percentage of patients that received IA rt-PA or abciximab as 
an adjunct to their procedure. p values are based on Fisher’s exact test.
Table 2. Comparison of outcome 
and procedure data on acute 
stroke patients treated with EST 
at a new CSC in year 1 and year 2 
(Fisher’s exact test)
Year 1 Year 2 p
Mean DTN, min 57.5 36.3 0.03
Min.–max. 54 – 121 35 – 37
Mean discharge mRS score 4.4 2.8 0.18
Min.–max. 2 – 6 1 – 6
Mean DTI, min 157 136 0.40
Min.–max. 70 – 222 72 – 201
Mean procedure length, min 135 117 0.51
Min.–max. 49 – 234 50 – 217
Mean Δ NIHSS score 5 6 0.88
Δ NIHSS range (–13)–21 0 – 14
Mean Δ NIHSS score = Average decrease in NIHSS following the 
procedure at 24 h after the procedure. The p value is based on significance 
testing as described in the text. Min.–max. = minimum to maximum values.
Table 3. Comparison of 
procedure and outcome 
variables from year 1 and year 2 
at a new CSC
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 With data from both year 1 and year 2, one-way ANOVA testing was performed to analyze 
the relationship between several variables (age, DTI time, NIHSS score change, and procedure 
length) and 30-day mortality ( table 4 ). A similar analysis was done between those variables 
and the TICI score (TICI score  ≥ 2b) ( table 4 ). Notably, NIHSS score improvement was signif-
icantly associated with decreased 30-day mortality (p = 0.008). We found a statistically signif-
icant trend between 30-day mortality and increasing age (p = 0.06) as well as between DTI 
time and mortality (p = 0.09). The other variables were not significantly associated with 
30-day mortality. A TICI score  ≥ 2b was significantly associated with improvement in NIHSS 
score (p = 0.01). This result is similar to recent reports  [9] .
 Process Data 
 For the patients receiving IV rt-PA, the average DTN time for administration of IV rt-PA 
decreased from year 1 to year 2 by approximately 20 min or 36% (p = 0.03;  table 3 ). The DTI 
time decreased from year 1 to year 2 but was not significantly different. Procedure length 
only slightly decreased from year 1 to year 2 (p = 0.51). In both years, approximately three 
quarters of procedures were done with stentrievers and about 40% used IA medications 
( table 2 ). Three procedural complications were identified in year 1 and one in year 2. In year 
1, there was one case of femoral artery dissection in an elderly patient with severe peripheral 
atherosclerotic disease. There were two intracerebral hemorrhages within 24 h of treatment 
and one case of ventilator-dependent respiratory failure requiring prolonged intubation and 
conversion to tracheostomy. Although the complication rate decreased from year 1 to year 2, 
the decrease was not statistically significant.
 Discussion 
 CSC Requirements 
 In 2000, the BAC established guidelines for a primary stroke center  [1, 10] , and in 2005, 
further requirements for a CSC were outlined  [2] . Since 2005, many academic and community 
medical centers have sought to establish CSCs. Retrospective analysis has suggested that 
patient outcomes are improved when stroke care is organized into such centers  [11–14] . For 
example, Kim et al.  [15]  calculated a 28% reduction in 30-day mortality after establishment 
of a CSC. Currently, there is a need to define expected progress during the initiation of a CSC 
and examine the benefits of EST. The aim of the present research is to address this need.
Variable 1 Variable 2 p
Δ NIHSS score 30-day mortality 0.01
Age 30-day mortality 0.06
DTI time 30-day mortality 0.09
Procedure length 30-day mortality 0.12
Preoperative NIHSS score 30-day mortality 0.50
Δ NIHSS score TICI score ≥2b 0.01
DTI time TICI score ≥2b 0.14
Procedure length TICI score ≥2b 0.32
Age TICI score ≥2b 0.72
Preoperative NIHSS score TICI score ≥2b 0.76
Δ NIHSS score = Change in NIHSS score 24 h following the procedure. 
30-day mortality and TICI score ≥2b are categorical variables.
Table 4. Results of the one-way 
ANOVA on pooled data from year 
1 and year 2
D
ow
nl
oa
de
d 
by
: 
71
.2
24
.1
19
.9
8 
- 5
/3
/2
01
5 
1:
58
:0
4 
PM
241Cerebrovasc Dis Extra 2014;4:235–242
 DOI: 10.1159/000370060 
E X T R A
 Benardete and Nair: Endovascular Stroke Therapy Results Improve over Time: The 
‘Learning Curve’ at a New Comprehensive Stoke Center 
www.karger.com/cee
© 2015 S. Karger AG, Basel
 Recent Randomized Clinical Trials 
 Several recent clinical trials have purported to show the limited efficacy of EST for acute 
ischemic stroke  [16–18] . These results created a great deal of discussion and re-evaluation of 
endovascular therapy protocols  [19] . While some have suggested a moratorium of EST for 
stroke  [20] , finer analysis of the data suggests that certain patients may benefit from this 
therapy  [19, 21, 22] . A number of authors have noted flaws in those trials including outdated 
treatment modalities, poor patient selection algorithms, and inadequate data analysis  [23] . 
Our center has continued to offer EST because our selection criteria differ from those of the 
reported trials. We select patients based on two necessary criteria: (1) imaging evidence of 
significant ischemic penumbra and a vessel occlusion of CT angiography, and (2) ineligibility 
for IV rt-PA or failure to improve after 1 h of IV rt-PA. In addition, the prospective, randomized 
trials published in 2013 suggested that EST has a safety profile similar to IV rt-PA  [16–18] .
 Outcome Improvements 
 At our CSC, we found that there was a statistically significant improvement in the 
number of independent patients at discharge (mRS  ≤ 2) following EST in year 2 compared 
to year 1. In addition, there were trends towards decreased mortality, decreased complica-
tions, and increased revascularization. Despite identical selection criteria, the patients in 
year 2 were slightly younger which may confound the results since our separate analysis 
has shown that older age is negatively correlated with a good outcome following EST. 
Others have shown a similar relationship between age and poor outcome  [24, 25] . Never-
theless, our data suggests that improvement in a number of outcome metrics (e.g. TICI 
score, change in NIHSS score, and complication rates) also occurred from year 1 to year 2, 
not all of which are likely due to the age variation in the patient population. Overall, for both 
years, approximately 40% of patients improved following EST. This result is similar to 
previous reports  [26, 27] .
 Process and Technical Improvements 
 Our data suggests that there are improvements over time in the delivery of EST. In our 
series, there was a decrease in mortality and morbidity from year 1 to year 2 as well as an 
increase in excellent revascularization (TICI score = 3), but these did not reach statistical 
significance. Although many individual improvements did not reach statistical significance, it 
is likely that the aggregate effect of these changes led to the statistically significant 
improvement in discharge status (mRS score  ≤ 2).
 We did observe statistically significant decreases in DTN time (p = 0.03) from year 1 to 
year 2. There were also trends towards decreased DTI time and procedure length from year 
1 to year 2. In their study of stentriever use, Eesa et al.  [28]  have also shown procedural 
improvements over time. In our ANOVA analysis, increasing DTI time is associated with 
increased mortality suggesting that accelerating delivery of care in these complex systems is 
of value.
 In summary, the initiation phase of a CSC is associated with significant improvements 
in outcome over time. These improvements may be attributed to increasing technical ability 
as well as to decreasing time in delivery of effective therapy. Furthermore, shorter time to 
intervention and successful revascularization are associated with improved outcomes.
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